Article
Amphiregulin deletion strongly attenuates the development of estrogen receptor-positive tumors in p53 mutant mice.
Breast cancer research and treatment - 1 Feb 2020
Meier David R, Girtman Megan A, Lofgren Kristopher A, Kenny Paraic A
Abstract excerpt
PURPOSE: The epidermal growth factor receptor ligand, Amphiregulin, is a transcriptional target of estrogen receptor alpha and is required for pubertal mammary gland development. Previous studies using immortalized human breast cancer cell line xenografts have suggested that Amphiregulin may be an important effector of estrogen receptor alpha during breast cancer development, at least in immune-compromised...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
